Syncom Formulations attracts investor attention on NSE
Syncom Formulations attracts investor attention on NSE due to increased retail interest and positive sentiment. The stock has seen a 15% rise in the past week, outperforming sector benchmarks. Trading volumes surged to 2.3x average, indicating momentum buildup. Fundamentally, it remains a small-cap with moderate revenue growth.
📊 STOCKS: SYNCOMF | 🏢 SECTOR: Pharma | #LOWIMPACT #Pharma
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.